Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Micronization Lipid-based formulations Spray dried dispersion Hot melt extrusion Provide bulk prototypes and dosing protocols for animal in vivo studies so teams can test promising approaches earlier without committing large API quantities upfront
Key Market Players: Glucagon-like Peptide-1 (GLP-1) Agonists Market Leaders Novo Nordisk Eli Lilly and Company AstraZeneca Sanofi Pfizer
For example, 0.5 mg desired dose divided by 5 mg/mL concentration equals 0.10 mL (10 units on an insulin syringe)
Livinski A, Joubert D, Terry N
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
